Insider · CIK 0001706176
Daniel R. Chevallard
cfoofficer
Files at LENZ (LENZ Therapeutics, Inc.). First filing Nov 7, 2025, latest Mar 30, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$114k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LENZ: LENZ Therapeutics, Inc.
LENZOct 9, 2026 · close 3.64
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | LENZbuy LENZ Therapeutics, Inc. | $64k 7,500 shares | +139% | 0% from low-83% from high | |
| 47Moderate | LENZ Therapeutics, Inc. | $50k 2,198 shares | +69% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | LENZ LENZ Therapeutics, Inc. | POpen-market purchase Common Stock | +7,500 | $8.57 | $64k | 12,886 | Mar 30, 2026 |
| Jan 2, 2026 | LENZ LENZ Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +84,200 | $0.00 | $0 | 84,200 | Jan 6, 2026 |
| Jan 2, 2026 | LENZ LENZ Therapeutics, Inc. | AGrant or award Restricted Stock Unitderivative | +14,000 | $0.00 | $0 | 14,000 | Jan 6, 2026 |
| Nov 7, 2025 | LENZ LENZ Therapeutics, Inc. | POpen-market purchase Common Stock | +20 | $22.71 | $454 | 3,208 | Nov 7, 2025 |
| Nov 7, 2025 | LENZ LENZ Therapeutics, Inc. | POpen-market purchase Common Stock | +2,178 | $22.76 | $50k | 5,386 | Nov 7, 2025 |
| Jan 9, 2025 | LENZ LENZ Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +70,444 | $0.00 | $0 | 70,444 | Jan 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.